Atanis Biotech is a company headquartered in Switzerland.
Atanis Biotech develops FAST-PASE®, a precision allergy diagnostic test that uses a small blood sample to measure cellular allergic responses safely and accurately without exposing patients to allergens.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.